Angiotensin II (100 nM) induced bi-phasic increases in cytosolic Ca 2+ level ([Ca 2+ ] i ) through the activation of angiotensin II type 1 receptor. Pharmacological examinations using 10 µM verapamil, 30 µM La 3+ , and 1 µM thapsigargin indicated that the first phase of the [Ca 2+ ] i -increase was mediated by Ca 2+ release from sarcoplasmic reticulum (SR) and Ca 2+ influx independently of voltage dependent Ca 2+ channel (VDC). In contrast, the second phase of [Ca 2+ ] i -increase was mediated by Ca 2+ influx through VDC. Although both [Ca 2+ ] i and myosin light chain (MLC)-phosphorylation at the first phase was apparently exceeded the threshold for contraction as estimated by high K + -induced responses, there was no appreciable contraction, indicating the dissociation between MLC phosphorylation and force during this phase. In contrast, the second phase of [Ca 2+ ] i was associated with the increases in both MLC phosphorylation and force. These results suggest that angiotensin II is a unique agonist which dissociates MLCphosphorylation from muscle force during the Ca 2+ releases from SR.
doi: 10.1292/jvms.17-0415 5.5. Ethylene diamine tetraacetic acid (EDTA, 1 µM) was also added to remove contaminating heavy metal ions, which catalyze oxidation of organic chemicals in PSS. The endothelium was removed by gently rubbing the intimal surface with the flat face of a pair of forceps moistened with PSS. The high concentration of KCl (72.7 mM) solution was prepared by replacing NaCl with equimolar KCl in PSS. All solutions had a pH of 7.4 when saturated with a 95% O 2 -5% CO 2 mixture at 37°C. Muscle tension was recorded isometrically with a force-displacement transducer. Each muscle strips were attached to a holder in a special organ bath (2 ml) with resting tension of 10 mN, and equilibrated for 30 to 60 min to obtained a stable contractility induced by 72.7 mM KCl.
Simultaneous measurement of muscle force and [Ca 2+ ] i was performed as reported by Sato et al. [24] with fluorescent Ca 2+ indicator, fura-PE3, which was less dye-leakage than fura-2. Rat aortic strips were treated with PSS containing acetoxymethylester of fura-PE3 (fura-PE3/AM, 5 µM) and less cytotoxic detergent, cremophor EL (0.02%), for 4-5 hr at room temperature. After loading of fura-PE3/AM, the muscle strips were washed with PSS at 37°C for 20 min to remove uncleaved fura-PE3/AM and held horizontally in a temperature-controlled organ bath (7 ml). One end of muscle strips was connected to a force-displacement transducer to monitor muscle force. Experiments were performed with a bio-fluorimeter (CAF-110, Japan Spectroscopic, Tokyo, Japan), and the ratio of 500 nm fluorescence excited at 340 nm (F340) to that excited at 380 nm (F380) (F340/F380) was used as indicator of [ 
MLC-phosphorylation
The amount of MLC-phosphorylation was measured according to the modified method described by Word et al. [31] . Strips of rat aorta were held isometrically under a resting tension force of 10 mN on stainless steel holders and quickly frozen in dry-ice acetone with 10% trichloroacetic acid (TCA). The strips were then incubated for several hours in the acetone/TCA solution until the temperature of the solution became around 0°C, and were then crushed in the liquid nitrogen. The crushed muscle powder was suspended in10% TCA and 10 mM dithiothreitol (DTT) (200-400 µl). The homogenate was centrifuged at 10,000 × g for 10 min and the pellet was washed with 500 µl diethyl ether several times to remove TCA. The pellet was then suspended in ureaglycerol buffer (25-75 µl) containing 20 mM Tris, 23 mM Glycine, 8 M urea, 10 mM DTT and 0.04% Bromophenol blue, and was centrifuged at 10,000 × g for 15 min. The supernatant was used as a sample.
The phosphorylated MLC was separated using Glycerol polyacrylamide gel electrophoresis (PAGE), the MLC or phosphorylated Ser 19 MLC was measured by western blot using anti-MLC antibody (donated by Dr. JT Stull).
Chemicals
The following chemicals were used: angiotensin II, thapsigargin (Sigma-Aldrich, St. Louis, MO, U.S.A.), cremophor EL, DTT, TCA, EDTA (Nacalai Tesque, Kyoto, Japan), KRH594 (gently donated by KISSEI Pharmaceutical Co., Ltd., Nagano, Japan) and fura-PE3/AM (Texas fluorescence laboratories, Austin, TX, U.S.A.).
Stastics
The numerical data were expressed as mean ± standard error. Differences between mean values were evaluated by Student's t-test and, where appropriate, analysis of variance (one-way ANOVA; Bonferroni's test) was performed.
RESULTS
As shown in Fig. 1 We then examined the relationship between [Ca 2+ ] i , MLC-phosphorylation and muscle force in the rat aorta stimulated with 72.7 mM KCl or 100 nM angiotensin II. As shown in Fig. 2A , in the muscles stimulated by 72.7 mM KCl for 5 sec, MLCphosphorylation and muscle force was increased in response to the increase in [Ca 2+ ] i to 130.59 ± 9.82%. At 15 sec, MLCphosphorylation further increased irrespective of decrease in [Ca 2+ ] i to 109.47 ± 2.71% with a further increase in muscle force.
In the rat aorta stimulated with angiotensin II (100 nM), [Ca 2+ ] i at the first and the second phases was almost identical (82.3 ± 6.8% at 30 sec and 80.1 ± 3.9% at 2 min) which was significantly less than high K + -induced increase in [Ca 2+ ] i at 5 and 15 sec. In response to these [Ca 2+ ] i increases, MLC-phosphorylation levels at 30 sec and 2 min increased to 71.2 ± 2.5% and 71.7 ± 4.1%, respectively, whose values were significantly greater than those in high K + stimulated muscle. Unexpectedly, the level of contraction was very small 30 sec after the addition of angiotensin II (Fig. 2B) .
Next, we attempted to characterize the Ca 2+ source due to angiotensin II (100 nM)-stimulation. Figure 3 shows (Fig. 3C) . Furthermore, the combination treatment with La 3+ , verapamil and 1 µM thapsigargin abolished either the first and the second phase of [Ca 2+ ] i . As for the contractile responses, even in the absence of the transient increase in [Ca 2+ ] i under the condition of the presence of verapamil, La 3+ and thapsigargin, angiotensin II induced first slowly developed contraction followed by a small sustained contraction, suggesting that at least a sustained contraction is mediated at least by Ca 2+ -independent mechanism.
We further measured the MLC-phosphorylation level of the rat aorta stimulated with 100 nM angiotensin II in the presence or absence of Ca 2+ release from SR and correlated of [Ca 2+ ] i with force. As shown in Fig. 4 , in the presence of verapamil plus La 3+ , angiotensin II induced phasic increase in [Ca 2+ ] i reaching its peak (66.0 ± 5.1%) after about 30 sec. This [Ca 2+ ] i -increase was associated with an increase in MLC phosphorylation (41.3 ± 2.8%). However, only a very small contraction was observed in response to the increase in MLC phosphorylation. Even in the absence of Ca 2+ release under the condition in which tissues were treated with verapamil, La 3+ and thapsigargin, angiotensin II increased MLC phosphorylation at 30 sec and 2 min. As was shown in the presence of verapamil and La 3+ , angiotensin II again induced only a very small contraction with a significant increase in MLC phosphorylation. [1, 20] , cessation of [Ca 2+ ] i increase may be due to the down-regulation of AT-receptors. We also found that the angiotensin II-induced contraction was completely inhibited by the AT 1 receptor antagonists, 1 µM losartan [7] or 10 nM KRH-594 [28] , supporting the [32] , may partly be involved in the first phase of the [Ca 2+ ] i -increase (Fig. 3B and 3C and our unpublished observation) . Data also indicated that treatment with verapamil, La 3+ and thapsigargin, a Ca 2+ pump inhibitor, abolished the first phase of the [Ca 2+ ] i -increase due to 100 nM angiotensin II in the absence of external Ca 2+ (Fig. 3D) . This result suggests that the first phase of [Ca 2+ ] i increase is mediated by Ca 2+ release from SR. Consisted with these observations, it has been reported that angiotensin II increases IP 3 formation following activation of phospholipase C β in cultured vascular smooth muscle cells [12, 26] . The relationship between MLC-phosphorylation and muscle force revealed that the level of the increases in [Ca 2+ ] i and MLC phosphorylation at 30 sec after the stimulation with angiotensin II (100 nM) was not reflected in the muscle force as shown in Fig. 2B . The same results were obtained in the conditions in which Ca 2+ influx had been inhibited by the presence of verapamil and La 3+ or the presence of verapamil, La 3+ and thapsigargin (Fig. 4B) . In contrast, in the muscle stimulated with 72.7 mM KCl, increased MLC-phosphorylation at 5 and 15 sec, whose values are smaller than those in the angiotensin II-induced responses at 30 sec, was associated with contraction. These contradictory results obtained in angiotensin II-and high K + -induced responses can not be explained by the possibility that the dissociation between MLC-phosphorylation and muscle force is due to the delay of force-transmission by elastic component, since the angiotensin II-induced responses were much slower than the high K + -induced responses.
DISCUSSION
Brizzolara-Gourdie and Webb [4] reported that angiotensin II stimulates cAMP formation to induce vasodilation in rat aorta. However, this is not the case with rat aorta, since enzyme-immunoassay showed that angiotensin II (100 nM) did not increase cAMP content (data not shown). Furthermore, angiotensin II did not inhibit 72.7 mM KCl-or 1 µM noradrenaline-induced contraction. These results suggest that MLC-phosphorylation 30 sec after stimulation with angiotensin II dissociates with muscle force by a cAMP-independent mechanisms. Tansey et al. [29] reported that phosphatase inhibitor, okadaic acid, inhibited carbachol-induced contractions without decreasing MLC phosphorylation in bovine trachea. Moreover, phorbol esters increased MLC phosphorylation and actin remodeling in bovine lung endothelium without increased contraction [3] . These results suggest the possibility that, like okadaic acid, angiotensin II may phosphorylates indirectly or directly some unknown regulatory proteins to dissociate MLC-phosphorylation and contraction in vascular smooth muscle. Further experiments are required to clarify this point.
The levels of phosphorylated MLC at 30 sec or 2 min after stimulation with angiotensin II (100 nM) were significantly higher than those of the response to 72.7 mM KCl at 5 and 15 sec. However, [Ca 2+ ] i at 30 sec or 2 min after addition of angiotensin II was significantly lower than those of 72.7 mM KCl. In addition, [Ca 2+ ] i -independent and MLC-phosphorylation dependent contraction was induced by angiotensin II in the presence of verapamil, La 3+ and thapsigargin (Fig.4) . These results suggest that angiotensin II sensitizes the MLC-phosphorylation step at a given [Ca 2+ ] i . This Ca 2+ sensitization might be mediated by inhibition of protein phosphatase through rhoA/ROCK pathway [16] and/or through PKC/PCI-17 pathway [18] .
We have previously shown the dissociation between the increase in [Ca 2+ ] i due to Ca 2+ release from SR and muscle force in the rat aorta stimulated with P 2 purinergic receptors [17] . In this report, we have demonstrated that ATP-induced increase in [Ca 2+ ] i was not associated with the increment of MLC phosphorylation, indicating the presence of localization of [Ca 2+ ] i that is not able to couple with contractile proteins [15] . In contrast, verapamil inhibited noradrenaline-induced contraction with decreases of MLC-P in rat aorta [13] , indicating that there is no dissociation between contraction and MLC-P. At present, we have no explanation for the marked difference between purinoceptor and α-adrenaline agonists and angiotensin II regarding the correlation between MLC phosphorylation and contraction, and it is also necessary to clarify this point in a future study.
In conclusion, angiotensin II induces contraction by an influx of Ca 2+ through VDC but not Ca 2+ release from SR. Angiotensin II is a unique receptor-agonist to dissociate MLC-phosphorylation from muscle force during the [Ca 2+ ] i -increase due to Ca 2+ releases from SR.
